Science First, Always: Agebox™ Introduces iKids-Connect and iKids-UriX, Expanding Its Evidence-Driven Pediatric Supplement Line

Powered by the Acesvia™ R&D Platform, the Two New Formulas Mark Agebox's Continued Commitment to Rigorous, Cell-Based Nutritional Research for Children

A Market in Need of Real Science

The pediatric supplement industry is saturated—but not with innovation. Most products on the market are built on recycled formulations, familiar ingredients redosed for children, and branding designed to appeal to anxious parents rather than inform them. For families who have done their research and for clinicians who hold their recommendations to a high standard, this landscape offers little confidence.

Agebox was founded specifically to address this gap. The company does not develop products to compete in crowded categories. It enters a space only when its internal research identifies a meaningful biological insight—and only after that insight has been rigorously validated from cellular models through to human data.

The Acesvia™ Platform: A Deliberate Route to Health

Every Agebox product is developed through Acesvia™, a proprietary research platform whose name draws from Aceso, the Greek goddess of healing, and via, Latin for pathway. The platform is built on primary human cells and iPSC-derived (induced pluripotent stem cell) models—among the most biologically relevant screening systems available outside of formal clinical trials.

Rather than testing whole-plant extracts as black boxes, Acesvia™ systematically deconstructs them. Plant materials are separated by part, extracted using water, oils, and organic solvents, and analyzed via HPLC-MS to identify individual compounds. Candidates showing biological activity are then purified through supercritical CO₂ extraction and crystallization to pharmaceutical-grade purity, stripping out inactive or interfering compounds and improving both potency and safety precision. Each confirmed bioactive is validated through ELISA-based assays before advancing to animal and human studies.

The full evidence pathway follows a structured sequence: cellular phenotypic screening → animal studies → small-cohort pilot trials → randomized controlled trials and real-world evidence. It is a development process closer in structure to pharmaceutical screening than to conventional supplement formulation—applied entirely to GRAS-compliant, food-grade ingredients.

Introducing the 2026 Product Launches

iKids-Connect™ delivers comprehensive day-and-night support for neuroimmune balance in children. Its formulation was developed using a co-culture model of iPSC-derived neurons and microglia to identify plant-derived bioactives capable of supporting the body's natural ability to maintain neuroimmune equilibrium—a physiological state considered critical to healthy cognitive and behavioral development.

iKids-UriX™ provides triple-action, plant-derived support for healthy uric acid levels in children, addressing a pediatric wellness need that has historically been underserved by the supplement industry.

Both products join iKids-Growth™, Agebox's flagship hormone-free growth support formula, in the company's expanding 2026 portfolio. Following a voluntary recall of a specific earlier production batch, Agebox undertook a comprehensive review of its supply chain and quality control protocols for iKids-Growth™. Affected customers were notified directly in accordance with established recall procedures. The returning batch reflects the outcome of that review. In addition to standard third-party testing for heavy metals, hormonal adulterants, pesticide residues, and microbial contaminants, Agebox has introduced expanded screening for growth hormone secretagogues — including GHRPs 1–6, Ibutamoren (MK-677), Ipamorelin, and Hexarelin — conducted by accredited independent laboratories. The new batch is expected to return to market shortly. All three products are available in child-appropriate capsule sizes and manufactured at an FDA-registered, cGMP-compliant facility.

Who This Is For

The families who find Agebox have usually already tried everything else. They've done the research. They've asked the hard questions. They've found the standard options lacking. So have the clinicians who want products they can actually recommend with confidence.

Agebox exists for them—and for every child who deserves a better option, backed by science that's genuinely rigorous.

Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About AGEBOX

AGEBOX Inc. is a U.S.-based biotechnology company that develops evidence-based dietary supplements to support children’s growth, cognition, and metabolic health. The company’s proprietary Acesvia™ Platform uses human cell models to identify and refine GRAS-compliant materials with measurable biological effects. Its formulas, supported by clinical trials, are designed to provide safe, natural, and scientifically grounded support for pediatric needs that are not fully addressed by existing solutions.

For more information, visit [www.agebox.com].

Disclaimer: The information provided in this article is for educational and informational purposes only and is not intended as medical advice. It should not be used to diagnose, treat, cure, or prevent any health condition. Always seek the guidance of a qualified healthcare professional with any questions you may have regarding your health, medical condition, or treatment options. The author and publisher make no representations or warranties about the accuracy, completeness, or suitability of the information provided. Use of this content is at your own risk. Digitaljournal.com does not take responsibility of the content published here.